Two new links and a warning about anti-science bullshit from the Republicans

First, if Wilmut wants to inject ESCs then I hope the lines are up for that. I’m a bit skeptical that they are. In any case, I strongly doubt he would be injecting people with lines known to form tumors.

The claim that embryonic stem cells can form every cell type of the body has not been proven yet, but it’s gotten around largely through media repetition. I don’t think there’s any malice to it, though it ought to be corrected. The scientific reviewer of my own book chapter on this certainly corrected me on this point; I had been making the same error as everyone else up until that point.

However, this little error isn’t comparable to the adult stem cell campaign, where it seems to me that there is a concerted effort to create a false opposition between two promising threads of research.

Finally: “The adult stem cell issue is important because they should be weighted in the ethical balance about how and whether to proceed with therapeutic cloning research.” It seems to me that this statement presumes an that we may have to decide *between* these two strands of research. I reject that very notion. If these different strands of research are aimed at achieving things and have different potential, then why should we be choosing one or the other?

I didn’t say you claimed that ES cells can make every cell in the body. I said that claim is continually made. I assume you are as indignant about this abuse of science as you are those perceived to come from the conservative side.

The adult stem cell issue is important because they should be weighted in the ethical balance about how and whether to proceed with therapeutic cloning research.

Cheers in 2006.

I would also like to comment on one of Chris’ posts above and affirm that he is correct in assuming that it is most often not the scientists themselves who are found publicly ‘hyping cures’. Many scientists (including myself) have been absolutely appalled upon reading claims made in mainstream news stories about their work. We in the scientific community know that this sort of hype will eventually work against us, as the general public is impatient for cures and will rally against us when we do not produce as quickly as they expected. Anyone who reads reputable science journals will quickly learn that scientists actually suffer from the opposite problem – we are loathe to make definitive, concrete claims about *anything*; we use downright wishy-washy language such as ‘these results *may* indicate that…’ or ‘these data *may suggest* a relationship between’. Use of more aggressive wording is actually sometimes a hallmark of a less-reputable publication.

This seems to cut at the heart of the matter. Not knowing how ESCs work or which tissues they can give rise to is not a valid argument against doing research on them, particularly when these happen to be the very things that the research is supposed to figure out! The goal of ESC research is to better understand the process of development, which is a necessary precursor to treating development-related diseases. To state that we don’t know how they develop is simply to say that we need more research.

If people such as Jay Wesley Smith had their way and such research were banned, we’d remain ignorant of how exactly ESCs differentiate. This will, at the very least, delay solving one of the biggest issues of developmental biology. It could possibly delay it forever. Perhaps Smith thinks this is a worthwhile trade-off for whatever ethical gains he thinks will be made by stopping the research. If so, it would be nice for him to state and defend that argument up-front rather than make the bizarre claim that because we don’t know about something, that’s a good reason not to conduct research on it.

1. Tumors. No one is denying that embyronic stem cells can form teratomas. But obviously no one is going to inject a person with an ESC line if it’s known to do this. And as I explained, we can watch and develop the lines to ensure that they no longer have this tumor-forming behavior. So why try to scare people about tumors?

2. When did I say embryonic stem cells have been proven to be able to form every different cell type in the body? I didn’t say it here, and in fact, I was very careful not to make this claim in my book.

3. You provide yet another list of advances using adult stem cells. So what? I’m not saying there’s anything wrong with this research, or denying that it exists. What I’m objecting to is the attempt to use findings in the adult stem cell area to denigrate or undermine embryonic research. I’m saying that the two fields of research are complimentary, not in opposition to one another. Therefore, it’s a bogus argument to cite adult stem cell advances in order to attack embryonic research, or suggest it’s unnecessary.

It was a pleasure to meet you as well on Tuesday. Thanks for engaging.

It’s right and fine and helps prevent unrealistic expectations to point out the many technical problems to be solved in order to use cloned stem cells in Alzheimer’s research, a truth often twisted, however, into a circular argument to NEVER ALLOW THE WORK TO BEGIN. “It’s difficult, so don’t try it.” Imagine politicians had had the means to hold back the Wright brothers with that sort of attitude. Throw in a pile of legislative threats and roadblocks, then complain science doesn’t lift off. Them eggheads can’t win, can they?

It cannot be about the money either, since public funds for embryonic stem cells in Western countries are fairly miniscule in comparison to expenses on other related research topics, including multipotent cells.

Anarcho-capitalists oppose public funding of basic research on principle. I don’t agree, but it’s a coherent position. For the Religious Right, however, the funding disputes are little more than a useful distraction from their own dogmatic extremism. For someone who seriously equates the life of a person with that of an embryo, still allowing the research to proceed with private funds is almost inevitably a tactical gambit on the way to total prohibition.

As to the “adult vs. embryonic” PR battle, anybody with even marginal knowledge of cell biology can see it’s a false dichotomy. The more genetic and epigenetic diversity of cell lines the research community has ready to hand for comparative study, the faster new tissue-engineering methods and molecular developmental mechanisms will be discovered.

The non-linear nature of biological inquiry thrives on open-mindedness, not ideological barriers. Conservatives decrying the catastrophic failures of socialist planned economy while trying to plan ahead and micro-manage the course of scientific discovery appear to be decisively more confused than ethical.

For example, you claim that my assertions about tumors and ES cells is “questionable.” Yet, the literature shows that ES cells do cause tumors in animal studies. For example, in one reported study of ES cell treatments on mice with Parkinson’s, the mice were given 1% of the usual dose and still 20% died of brain tumors. Tumors (in addition to tissue rejection) str a big issue and provide just one reason why it is unlikely that the FDA will approve ES cell human studies in the near future.

Then, of course, there is the problem that scientists cannot yet morph these cells into any tissue they want. We don’t even know they will ever be able to do so. Any other assertion, such as the oft-heard claim that ES cells “can become any tissue in the body,” is speculation, or perhaps better stated, hypothosis. This isn’t the same thing as having been scientifically verified, and you of all people, should hold yourself to that standard in your advocacy, clearly labeling speculation, hypothesis, and hope apart from verified science.

Nor is bone marrow necessarily the primary source of adult stem cell therapies. For example, juvenile diabetes has been cured in mice with spleen stem cells. The FDA has approved the experiment for human tests. Nothing close to that on the embryonic side. Blood and fat stem cells have been shown to help heal heart tissue in human and animal studies. Umbilical cord blood stem cells have helped restore some movement and sensation to a paralyzed woman, as published in a peer reviewed journal. Mice with severed spinal coreds have been materially improved with olfactory stem cells. Annecdotally, this has also worked in humans. There is, I am told, going to be a peer reviewed report about this work published this year.

Great meeting you the other night, by the way. It was an interesting event.

I agree generally there are a lot of hypotheticals here, but scientists are really thinking seriously about doing this stuff. Finally, are the scientists the ones hyping Alzheimer’s cures, or the advocates? I suspect it’s the latter, not the former.

You are correct that stem cells CAN be connected to Alzheimer’s through a convoluted stream of hypotheticals, but there is no doubt that scientists abuse this link to manipulate the public. Why would they do such a thing? Quite simply, scientists are human beings with distinct self-interests and political motivations. When science is your livelihood and your research is government funded, survival requires “selling” your research to an undereducated public. Scientists sell cures because cures sell science.

In my opinion, declaring these assertions over-hyped and irresponsible does not amount to “using a very selective description of what this research is really all about.” For the forseeable future, this research is ENTIRELY about learning “how to grow specialized tissues that can then be used to cure diseases.” This is indeed a PREREQUISITE for the Alzheimer’s research you describe. Alzheimer’s is a neurodegenerative disease. We need to understand what triggers formation of amyloid plaques and neurofibrillary tangles, and how they exert toxicity on neurons. The use of SCNT to create “embryonic stem cell lines with the genetic signature of Alzheimer’s” is just the beginning. These cell lines must be coaxed to develop into neurons (a specialized tissue indeed) before they can be studied as a model for Alzheimer’s. They can then complement current Alzheimer’s studies using neuronal cell lines not derived from stem cells (PC12 cells, for instance). Do you know how many technical hurdles must be cleared before these cells can exist? It certainly boggles my neurons.